Privia Health Group, Inc. (PRVA) 10-Year Financial Performance & Capital Metrics

PRVA • • Industrial / General

HealthcareHealthcare ITClinical Software & EHR SystemsProvider Management Solutions

AboutPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.Show more

Revenue $1.74B +4.7%
EBITDA $24M -10.8%
Net Income $14M -37.7%
EPS (Diluted) 0.11 -42.1%
Gross Margin 10.19% +4.5%
EBITDA Margin 1.4% -14.8%
Operating Margin 0.98% -21.5%
Net Margin 0.83% -40.5%
ROE 2.23% -45.6%
ROIC 6.01% -20.7%
Debt/Equity 0.01 -40.1%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 17.2%
✓Efficient asset utilization: 1.5x turnover

✗Weaknesses

✗Weak 3Y average ROE of 1.5%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y17.17%

3Y21.58%

TTM19.01%

Profit (Net Income) CAGR

10Y-

5Y11.78%

3Y-

TTM41.66%

EPS CAGR

10Y-

5Y7.12%

3Y-

TTM35.7%

ROCE

10Y Avg-4.93%

5Y Avg-9.32%

3Y Avg0.83%

Latest2.61%

Peer Comparison

Provider Management Solutions

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PRVAPrivia Health Group, Inc.	2.93B	23.86	216.91	4.74%	0.89%	2.38%	3.55%	0.01
PGNYProgyny, Inc.	2.1B	24.31	42.65	7.22%	4.46%	10.1%	8.29%	0.05
DOCSDoximity, Inc.	5.64B	41.05	36.98	19.98%	40.72%	23.1%	4.73%	0.01
HSTMHealthStream, Inc.	653.89M	22.04	33.39	4.51%	6.93%	5.93%	4.51%	0.06
SPOKSpok Holdings, Inc.	272.51M	13.23	18.12	-0.99%	11.88%	11.16%	9.44%	0.06
BTSGBrightSpring Health Services, Inc. Common Stock	7.14B	39.60	-423.08	27.65%	1.04%	7.12%		1.76

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	657.61M	786.36M	817.08M	966.22M	1.36B	1.66B	1.74B
Revenue Growth %	-	0.2%	0.04%	0.18%	0.4%	0.22%	0.05%
Cost of Goods Sold+	601.15M	717.89M	734.49M	902.56M	1.22B	1.5B	1.56B
COGS % of Revenue	0.91%	0.91%	0.9%	0.93%	0.9%	0.9%	0.9%
Gross Profit+	56.46M	68.47M	82.58M	63.66M	134.78M	161.5M	176.85M
Gross Margin %	0.09%	0.09%	0.1%	0.07%	0.1%	0.1%	0.1%
Gross Profit Growth %	-	0.21%	0.21%	-0.23%	1.12%	0.2%	0.1%
Operating Expenses+	54.3M	52.41M	57.2M	281.1M	153.9M	140.85M	159.87M
OpEx % of Revenue	0.08%	0.07%	0.07%	0.29%	0.11%	0.08%	0.09%
Selling, General & Admin	53.23M	50.98M	55.36M	278.63M	149.33M	134.32M	152.6M
SG&A % of Revenue	0.08%	0.06%	0.07%	0.29%	0.11%	0.08%	0.09%
Research & Development	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	1.07M	1.43M	1.84M	2.46M	4.57M	6.53M	7.27M
Operating Income+	2.15M	16.06M	25.38M	-217.44M	-19.12M	20.65M	16.98M
Operating Margin %	0%	0.02%	0.03%	-0.23%	-0.01%	0.01%	0.01%
Operating Income Growth %	-	6.45%	0.58%	-9.57%	0.91%	2.08%	-0.18%
EBITDA+	3.23M	17.49M	27.22M	-214.97M	-14.55M	27.18M	24.25M
EBITDA Margin %	0%	0.02%	0.03%	-0.22%	-0.01%	0.02%	0.01%
EBITDA Growth %	-	4.42%	0.56%	-8.9%	0.93%	2.87%	-0.11%
D&A (Non-Cash Add-back)	1.07M	1.43M	1.84M	2.46M	4.57M	6.53M	7.27M
EBIT	2.15M	16.06M	25.38M	-217.44M	-19.12M	20.65M	16.98M
Net Interest Income+	-6.42M	-6.91M	-1.92M	-1.07M	0	8.37M	10.89M
Interest Income	0	0	0	0	0	8.37M	10.89M
Interest Expense	6.42M	6.91M	1.92M	1.07M	0	0	0
Other Income/Expense	-6.42M	-6.91M	-1.92M	-1.07M	542K	8.37M	10.89M
Pretax Income+	-4.26M	9.15M	23.46M	-218.51M	-18.58M	29.02M	27.87M
Pretax Margin %	-0.01%	0.01%	0.03%	-0.23%	-0.01%	0.02%	0.02%
Income Tax+	-76K	1.21M	-7.44M	-27.86M	-6.52M	7.99M	10.83M
Effective Tax Rate %	0.71%	0.9%	1.33%	0.86%	0.46%	0.8%	0.52%
Net Income+	-3.04M	8.24M	31.24M	-188.23M	-8.59M	23.08M	14.38M
Net Margin %	-0%	0.01%	0.04%	-0.19%	-0.01%	0.01%	0.01%
Net Income Growth %	-	3.71%	2.79%	-7.02%	0.95%	3.69%	-0.38%
Net Income (Continuing)	-4.19M	7.95M	30.9M	-190.65M	-12.06M	21.03M	17.04M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	-2.46M	-2.76M	-3.1M	23.31M	19.95M	45.95M	48.26M
EPS (Diluted)+	-0.03	0.08	0.30	-1.77	-0.11	0.19	0.11
EPS Growth %	-	3.64%	2.85%	-6.9%	0.94%	2.73%	-0.42%
EPS (Basic)	-0.03	0.08	0.30	-1.77	-0.11	0.20	0.12
Diluted Shares Outstanding	102.79M	105.71M	105.71M	107.84M	110.7M	124.69M	125.61M
Basic Shares Outstanding	102.79M	105.71M	105.71M	107.84M	110.7M	116.73M	119.4M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	115.49M	129.6M	190.08M	446.68M	551.96M	700.8M	834.82M
Cash & Short-Term Investments	39.11M	46.89M	84.63M	320.58M	347.99M	389.51M	491.15M
Cash Only	39.11M	46.89M	84.63M	320.58M	347.99M	389.51M	491.15M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	71.16M	77.34M	99.12M	117.4M	189.6M	290.77M	316.18M
Days Sales Outstanding	39.5	35.9	44.28	44.35	51.01	64.02	66.46
Inventory	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-
Other Current Assets	0	0	0	0	14.37M	20.52M	27.5M
Total Non-Current Assets+	134M	140.61M	138.88M	239.7M	240.85M	299.1M	300.96M
Property, Plant & Equipment	698K	5.62M	4.81M	14.14M	11.47M	8.94M	6.07M
Fixed Asset Turnover	942.13x	139.87x	169.73x	68.35x	118.23x	185.49x	286.06x
Goodwill	118.66M	118.66M	118.66M	127.94M	126.94M	138.75M	141.62M
Intangible Assets	7.26M	6.62M	5.98M	59.74M	57.39M	107.63M	109.81M
Long-Term Investments	0	0	0	0	0	0	0
Other Non-Current Assets	7.37M	9.7M	4.47M	4.52M	4.68M	8.58M	17.09M
Total Assets+	249.49M	270.2M	328.97M	686.37M	792.81M	999.9M	1.14B
Asset Turnover	2.64x	2.91x	2.48x	1.41x	1.71x	1.66x	1.53x
Asset Growth %	-	0.08%	0.22%	1.09%	0.16%	0.26%	0.14%
Total Current Liabilities+	101.32M	115.22M	146.94M	190.46M	264.27M	386.95M	449.15M
Accounts Payable	4.67M	525K	5.24M	2.97M	6.73M	7.88M	9.76M
Days Payables Outstanding	2.83	0.27	2.6	1.2	2.01	1.92	2.28
Short-Term Debt	7.13M	3.38M	875K	875K	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0
Other Current Liabilities	4.39M	86.86M	112.98M	148.2M	214.6M	332.05M	370.61M
Current Ratio	1.14x	1.12x	1.29x	2.35x	2.09x	1.81x	1.86x
Quick Ratio	1.14x	1.12x	1.29x	2.35x	2.09x	1.81x	1.86x
Cash Conversion Cycle	-	-	-	-	-	-	-
Total Non-Current Liabilities+	62.12M	47.53M	38.38M	45.73M	9.49M	5.56M	3.19M
Long-Term Debt	59.87M	39.73M	32.78M	31.69M	0	0	0
Capital Lease Obligations	0	0	0	11.04M	8.49M	5.25M	3.04M
Deferred Tax Liabilities	0	2.88M	0	0	0	0	0
Other Non-Current Liabilities	2.25M	4.92M	5.59M	3M	1M	313K	153K
Total Liabilities	163.44M	162.75M	185.32M	236.19M	273.76M	392.51M	452.34M
Total Debt+	67M	43.1M	33.66M	46.5M	11.5M	8.29M	5.59M
Net Debt	27.89M	-3.79M	-50.97M	-274.08M	-336.49M	-381.22M	-485.56M
Debt / Equity	0.78x	0.40x	0.23x	0.10x	0.02x	0.01x	0.01x
Debt / EBITDA	20.78x	2.46x	1.24x	-	-	0.30x	0.23x
Net Debt / EBITDA	8.65x	-0.22x	-1.87x	-	-	-14.02x	-20.02x
Interest Coverage	0.34x	2.32x	13.24x	-203.21x	-	-	-
Total Equity+	86.04M	107.46M	143.65M	450.18M	519.05M	607.39M	683.45M
Equity Growth %	-	0.25%	0.34%	2.13%	0.15%	0.17%	0.13%
Book Value per Share	0.84	1.02	1.36	4.17	4.69	4.87	5.44
Total Shareholders' Equity	88.5M	110.21M	146.75M	426.87M	499.09M	561.44M	635.18M
Common Stock	959K	959K	960K	1.08M	1.15M	1.18M	1.2M
Retained Earnings	-59.37M	-51.12M	-19.88M	-208.11M	-216.69M	-193.61M	-179.23M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0
Minority Interest	-2.46M	-2.76M	-3.1M	23.31M	19.95M	45.95M	48.26M

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	5.25M	24.36M	38.89M	55.06M	47.2M	80.78M	109.28M
Operating CF Margin %	0.01%	0.03%	0.05%	0.06%	0.03%	0.05%	0.06%
Operating CF Growth %	-	3.64%	0.6%	0.42%	-0.14%	0.71%	0.35%
Net Income	-4.19M	7.95M	30.9M	-190.65M	-12.06M	23.08M	14.38M
Depreciation & Amortization	1.07M	1.43M	1.83M	2.46M	4.57M	6.53M	7.27M
Stock-Based Compensation	1.94M	207K	484K	253.53M	67.36M	0	0
Deferred Taxes	-258K	716K	-7.83M	-28.41M	-7M	7.46M	8.82M
Other Non-Cash Items	147K	332K	134K	157K	687K	35.05M	59.34M
Working Capital Changes	6.54M	13.73M	13.37M	17.97M	-6.35M	8.66M	19.47M
Change in Receivables	320K	-6.18M	-21.78M	-14.64M	-72.2M	-96.88M	-19.82M
Change in Inventory	0	0	0	0	0	0	0
Change in Payables	-983K	-4.14M	4.71M	0	6.85M	118.36M	52.85M
Cash from Investing+	-165K	-5.71M	-380K	-32.77M	-104K	-48.01M	-10.32M
Capital Expenditures	-220K	-5.71M	-380K	-547K	-104K	-113K	-5.02M
CapEx % of Revenue	0%	0.01%	0%	0%	0%	0%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-125K	0	0
Cash from Financing+	15.36M	-10.87M	-767K	213.66M	-19.68M	8.74M	2.68M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	106K	0	108K	-9.15M	125K	0	0
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	5.03M	18.65M	38.51M	54.51M	47.09M	80.67M	104.26M
FCF Margin %	0.01%	0.02%	0.05%	0.06%	0.03%	0.05%	0.06%
FCF Growth %	-	2.71%	1.07%	0.42%	-0.14%	0.71%	0.29%
FCF per Share	0.05	0.18	0.36	0.51	0.43	0.65	0.83
FCF Conversion (FCF/Net Income)	-1.72x	2.95x	1.24x	-0.29x	-5.50x	3.50x	7.60x
Interest Paid	3.72M	9.2M	1.93M	888K	713K	0	0
Taxes Paid	27K	316K	381K	504K	307K	0	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-3.54%	8.52%	24.88%	-63.39%	-1.77%	4.1%	2.23%
Return on Invested Capital (ROIC)	1.42%	11.07%	19.39%	-121.35%	-8%	7.58%	6.01%
Gross Margin	8.59%	8.71%	10.11%	6.59%	9.93%	9.74%	10.19%
Net Margin	-0.46%	1.05%	3.82%	-19.48%	-0.63%	1.39%	0.83%
Debt / Equity	0.78x	0.40x	0.23x	0.10x	0.02x	0.01x	0.01x
Interest Coverage	0.34x	2.32x	13.24x	-203.21x	-	-	-
FCF Conversion	-1.72x	2.95x	1.24x	-0.29x	-5.50x	3.50x	7.60x
Revenue Growth	-	19.58%	3.91%	18.25%	40.41%	22.19%	4.74%

Revenue by Segment

	2021	2022	2023	2024
FFS-Patient Care	772.48M	869.16M	976.69M	1.15B
FFS-Patient Care Growth	-	12.52%	12.37%	17.35%
Capitated Revenue	-	218.46M	338.73M	212.99M
Capitated Revenue Growth	-	-	55.05%	-37.12%
Shared Savings	83.02M	132.62M	170.14M	179.2M
Shared Savings Growth	-	59.75%	28.30%	5.32%
FFS-Administrative Services	68.81M	94.93M	113.15M	125.43M
FFS-Administrative Services Growth	-	37.97%	19.20%	10.85%
Care Management Fee (PMPM)	36.5M	35.54M	50.52M	64.07M
Care Management Fee (PMPM) Growth	-	-2.64%	42.14%	26.82%
Other Revenue	5.41M	5.95M	8.5M	8.55M
Other Revenue Growth	-	9.84%	43.00%	0.52%

Frequently Asked Questions

Valuation & Price

Privia Health Group, Inc. (PRVA) has a price-to-earnings (P/E) ratio of 216.9x. This suggests investors expect higher future growth.

Growth & Financials

Privia Health Group, Inc. (PRVA) reported $2.04B in revenue for fiscal year 2024. This represents a 211% increase from $657.6M in 2018.

Privia Health Group, Inc. (PRVA) grew revenue by 4.7% over the past year. Growth has been modest.

Yes, Privia Health Group, Inc. (PRVA) is profitable, generating $18.2M in net income for fiscal year 2024 (0.8% net margin).

Dividend & Returns

Privia Health Group, Inc. (PRVA) has a return on equity (ROE) of 2.2%. This is below average, suggesting room for improvement.

Privia Health Group, Inc. (PRVA) generated $109.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Privia Health Group, Inc. (PRVA) 10-Year Financial Performance & Capital Metrics

PRVA • • Industrial / General

HealthcareHealthcare ITClinical Software & EHR SystemsProvider Management Solutions

Revenue $1.74B +4.7%
EBITDA $24M -10.8%
Net Income $14M -37.7%
EPS (Diluted) 0.11 -42.1%
Gross Margin 10.19% +4.5%
EBITDA Margin 1.4% -14.8%
Operating Margin 0.98% -21.5%
Net Margin 0.83% -40.5%
ROE 2.23% -45.6%
ROIC 6.01% -20.7%
Debt/Equity 0.01 -40.1%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 17.2%
✓Efficient asset utilization: 1.5x turnover

✗Weaknesses

✗Weak 3Y average ROE of 1.5%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y17.17%

3Y21.58%

TTM19.01%

Profit (Net Income) CAGR

10Y-

5Y11.78%

3Y-

TTM41.66%

EPS CAGR

10Y-

5Y7.12%

3Y-

TTM35.7%

ROCE

10Y Avg-4.93%

5Y Avg-9.32%

3Y Avg0.83%

Latest2.61%

Peer Comparison

Provider Management Solutions

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PRVAPrivia Health Group, Inc.	2.93B	23.86	216.91	4.74%	0.89%	2.38%	3.55%	0.01
PGNYProgyny, Inc.	2.1B	24.31	42.65	7.22%	4.46%	10.1%	8.29%	0.05
DOCSDoximity, Inc.	5.64B	41.05	36.98	19.98%	40.72%	23.1%	4.73%	0.01
HSTMHealthStream, Inc.	653.89M	22.04	33.39	4.51%	6.93%	5.93%	4.51%	0.06
SPOKSpok Holdings, Inc.	272.51M	13.23	18.12	-0.99%	11.88%	11.16%	9.44%	0.06
BTSGBrightSpring Health Services, Inc. Common Stock	7.14B	39.60	-423.08	27.65%	1.04%	7.12%		1.76

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	657.61M	786.36M	817.08M	966.22M	1.36B	1.66B	1.74B
Revenue Growth %	-	0.2%	0.04%	0.18%	0.4%	0.22%	0.05%
Cost of Goods Sold+	601.15M	717.89M	734.49M	902.56M	1.22B	1.5B	1.56B
COGS % of Revenue	0.91%	0.91%	0.9%	0.93%	0.9%	0.9%	0.9%
Gross Profit+	56.46M	68.47M	82.58M	63.66M	134.78M	161.5M	176.85M
Gross Margin %	0.09%	0.09%	0.1%	0.07%	0.1%	0.1%	0.1%
Gross Profit Growth %	-	0.21%	0.21%	-0.23%	1.12%	0.2%	0.1%
Operating Expenses+	54.3M	52.41M	57.2M	281.1M	153.9M	140.85M	159.87M
OpEx % of Revenue	0.08%	0.07%	0.07%	0.29%	0.11%	0.08%	0.09%
Selling, General & Admin	53.23M	50.98M	55.36M	278.63M	149.33M	134.32M	152.6M
SG&A % of Revenue	0.08%	0.06%	0.07%	0.29%	0.11%	0.08%	0.09%
Research & Development	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	1.07M	1.43M	1.84M	2.46M	4.57M	6.53M	7.27M
Operating Income+	2.15M	16.06M	25.38M	-217.44M	-19.12M	20.65M	16.98M
Operating Margin %	0%	0.02%	0.03%	-0.23%	-0.01%	0.01%	0.01%
Operating Income Growth %	-	6.45%	0.58%	-9.57%	0.91%	2.08%	-0.18%
EBITDA+	3.23M	17.49M	27.22M	-214.97M	-14.55M	27.18M	24.25M
EBITDA Margin %	0%	0.02%	0.03%	-0.22%	-0.01%	0.02%	0.01%
EBITDA Growth %	-	4.42%	0.56%	-8.9%	0.93%	2.87%	-0.11%
D&A (Non-Cash Add-back)	1.07M	1.43M	1.84M	2.46M	4.57M	6.53M	7.27M
EBIT	2.15M	16.06M	25.38M	-217.44M	-19.12M	20.65M	16.98M
Net Interest Income+	-6.42M	-6.91M	-1.92M	-1.07M	0	8.37M	10.89M
Interest Income	0	0	0	0	0	8.37M	10.89M
Interest Expense	6.42M	6.91M	1.92M	1.07M	0	0	0
Other Income/Expense	-6.42M	-6.91M	-1.92M	-1.07M	542K	8.37M	10.89M
Pretax Income+	-4.26M	9.15M	23.46M	-218.51M	-18.58M	29.02M	27.87M
Pretax Margin %	-0.01%	0.01%	0.03%	-0.23%	-0.01%	0.02%	0.02%
Income Tax+	-76K	1.21M	-7.44M	-27.86M	-6.52M	7.99M	10.83M
Effective Tax Rate %	0.71%	0.9%	1.33%	0.86%	0.46%	0.8%	0.52%
Net Income+	-3.04M	8.24M	31.24M	-188.23M	-8.59M	23.08M	14.38M
Net Margin %	-0%	0.01%	0.04%	-0.19%	-0.01%	0.01%	0.01%
Net Income Growth %	-	3.71%	2.79%	-7.02%	0.95%	3.69%	-0.38%
Net Income (Continuing)	-4.19M	7.95M	30.9M	-190.65M	-12.06M	21.03M	17.04M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	-2.46M	-2.76M	-3.1M	23.31M	19.95M	45.95M	48.26M
EPS (Diluted)+	-0.03	0.08	0.30	-1.77	-0.11	0.19	0.11
EPS Growth %	-	3.64%	2.85%	-6.9%	0.94%	2.73%	-0.42%
EPS (Basic)	-0.03	0.08	0.30	-1.77	-0.11	0.20	0.12
Diluted Shares Outstanding	102.79M	105.71M	105.71M	107.84M	110.7M	124.69M	125.61M
Basic Shares Outstanding	102.79M	105.71M	105.71M	107.84M	110.7M	116.73M	119.4M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	115.49M	129.6M	190.08M	446.68M	551.96M	700.8M	834.82M
Cash & Short-Term Investments	39.11M	46.89M	84.63M	320.58M	347.99M	389.51M	491.15M
Cash Only	39.11M	46.89M	84.63M	320.58M	347.99M	389.51M	491.15M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	71.16M	77.34M	99.12M	117.4M	189.6M	290.77M	316.18M
Days Sales Outstanding	39.5	35.9	44.28	44.35	51.01	64.02	66.46
Inventory	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-
Other Current Assets	0	0	0	0	14.37M	20.52M	27.5M
Total Non-Current Assets+	134M	140.61M	138.88M	239.7M	240.85M	299.1M	300.96M
Property, Plant & Equipment	698K	5.62M	4.81M	14.14M	11.47M	8.94M	6.07M
Fixed Asset Turnover	942.13x	139.87x	169.73x	68.35x	118.23x	185.49x	286.06x
Goodwill	118.66M	118.66M	118.66M	127.94M	126.94M	138.75M	141.62M
Intangible Assets	7.26M	6.62M	5.98M	59.74M	57.39M	107.63M	109.81M
Long-Term Investments	0	0	0	0	0	0	0
Other Non-Current Assets	7.37M	9.7M	4.47M	4.52M	4.68M	8.58M	17.09M
Total Assets+	249.49M	270.2M	328.97M	686.37M	792.81M	999.9M	1.14B
Asset Turnover	2.64x	2.91x	2.48x	1.41x	1.71x	1.66x	1.53x
Asset Growth %	-	0.08%	0.22%	1.09%	0.16%	0.26%	0.14%
Total Current Liabilities+	101.32M	115.22M	146.94M	190.46M	264.27M	386.95M	449.15M
Accounts Payable	4.67M	525K	5.24M	2.97M	6.73M	7.88M	9.76M
Days Payables Outstanding	2.83	0.27	2.6	1.2	2.01	1.92	2.28
Short-Term Debt	7.13M	3.38M	875K	875K	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0
Other Current Liabilities	4.39M	86.86M	112.98M	148.2M	214.6M	332.05M	370.61M
Current Ratio	1.14x	1.12x	1.29x	2.35x	2.09x	1.81x	1.86x
Quick Ratio	1.14x	1.12x	1.29x	2.35x	2.09x	1.81x	1.86x
Cash Conversion Cycle	-	-	-	-	-	-	-
Total Non-Current Liabilities+	62.12M	47.53M	38.38M	45.73M	9.49M	5.56M	3.19M
Long-Term Debt	59.87M	39.73M	32.78M	31.69M	0	0	0
Capital Lease Obligations	0	0	0	11.04M	8.49M	5.25M	3.04M
Deferred Tax Liabilities	0	2.88M	0	0	0	0	0
Other Non-Current Liabilities	2.25M	4.92M	5.59M	3M	1M	313K	153K
Total Liabilities	163.44M	162.75M	185.32M	236.19M	273.76M	392.51M	452.34M
Total Debt+	67M	43.1M	33.66M	46.5M	11.5M	8.29M	5.59M
Net Debt	27.89M	-3.79M	-50.97M	-274.08M	-336.49M	-381.22M	-485.56M
Debt / Equity	0.78x	0.40x	0.23x	0.10x	0.02x	0.01x	0.01x
Debt / EBITDA	20.78x	2.46x	1.24x	-	-	0.30x	0.23x
Net Debt / EBITDA	8.65x	-0.22x	-1.87x	-	-	-14.02x	-20.02x
Interest Coverage	0.34x	2.32x	13.24x	-203.21x	-	-	-
Total Equity+	86.04M	107.46M	143.65M	450.18M	519.05M	607.39M	683.45M
Equity Growth %	-	0.25%	0.34%	2.13%	0.15%	0.17%	0.13%
Book Value per Share	0.84	1.02	1.36	4.17	4.69	4.87	5.44
Total Shareholders' Equity	88.5M	110.21M	146.75M	426.87M	499.09M	561.44M	635.18M
Common Stock	959K	959K	960K	1.08M	1.15M	1.18M	1.2M
Retained Earnings	-59.37M	-51.12M	-19.88M	-208.11M	-216.69M	-193.61M	-179.23M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0
Minority Interest	-2.46M	-2.76M	-3.1M	23.31M	19.95M	45.95M	48.26M

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	5.25M	24.36M	38.89M	55.06M	47.2M	80.78M	109.28M
Operating CF Margin %	0.01%	0.03%	0.05%	0.06%	0.03%	0.05%	0.06%
Operating CF Growth %	-	3.64%	0.6%	0.42%	-0.14%	0.71%	0.35%
Net Income	-4.19M	7.95M	30.9M	-190.65M	-12.06M	23.08M	14.38M
Depreciation & Amortization	1.07M	1.43M	1.83M	2.46M	4.57M	6.53M	7.27M
Stock-Based Compensation	1.94M	207K	484K	253.53M	67.36M	0	0
Deferred Taxes	-258K	716K	-7.83M	-28.41M	-7M	7.46M	8.82M
Other Non-Cash Items	147K	332K	134K	157K	687K	35.05M	59.34M
Working Capital Changes	6.54M	13.73M	13.37M	17.97M	-6.35M	8.66M	19.47M
Change in Receivables	320K	-6.18M	-21.78M	-14.64M	-72.2M	-96.88M	-19.82M
Change in Inventory	0	0	0	0	0	0	0
Change in Payables	-983K	-4.14M	4.71M	0	6.85M	118.36M	52.85M
Cash from Investing+	-165K	-5.71M	-380K	-32.77M	-104K	-48.01M	-10.32M
Capital Expenditures	-220K	-5.71M	-380K	-547K	-104K	-113K	-5.02M
CapEx % of Revenue	0%	0.01%	0%	0%	0%	0%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-125K	0	0
Cash from Financing+	15.36M	-10.87M	-767K	213.66M	-19.68M	8.74M	2.68M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	106K	0	108K	-9.15M	125K	0	0
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	5.03M	18.65M	38.51M	54.51M	47.09M	80.67M	104.26M
FCF Margin %	0.01%	0.02%	0.05%	0.06%	0.03%	0.05%	0.06%
FCF Growth %	-	2.71%	1.07%	0.42%	-0.14%	0.71%	0.29%
FCF per Share	0.05	0.18	0.36	0.51	0.43	0.65	0.83
FCF Conversion (FCF/Net Income)	-1.72x	2.95x	1.24x	-0.29x	-5.50x	3.50x	7.60x
Interest Paid	3.72M	9.2M	1.93M	888K	713K	0	0
Taxes Paid	27K	316K	381K	504K	307K	0	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-3.54%	8.52%	24.88%	-63.39%	-1.77%	4.1%	2.23%
Return on Invested Capital (ROIC)	1.42%	11.07%	19.39%	-121.35%	-8%	7.58%	6.01%
Gross Margin	8.59%	8.71%	10.11%	6.59%	9.93%	9.74%	10.19%
Net Margin	-0.46%	1.05%	3.82%	-19.48%	-0.63%	1.39%	0.83%
Debt / Equity	0.78x	0.40x	0.23x	0.10x	0.02x	0.01x	0.01x
Interest Coverage	0.34x	2.32x	13.24x	-203.21x	-	-	-
FCF Conversion	-1.72x	2.95x	1.24x	-0.29x	-5.50x	3.50x	7.60x
Revenue Growth	-	19.58%	3.91%	18.25%	40.41%	22.19%	4.74%

Revenue by Segment

	2021	2022	2023	2024
FFS-Patient Care	772.48M	869.16M	976.69M	1.15B
FFS-Patient Care Growth	-	12.52%	12.37%	17.35%
Capitated Revenue	-	218.46M	338.73M	212.99M
Capitated Revenue Growth	-	-	55.05%	-37.12%
Shared Savings	83.02M	132.62M	170.14M	179.2M
Shared Savings Growth	-	59.75%	28.30%	5.32%
FFS-Administrative Services	68.81M	94.93M	113.15M	125.43M
FFS-Administrative Services Growth	-	37.97%	19.20%	10.85%
Care Management Fee (PMPM)	36.5M	35.54M	50.52M	64.07M
Care Management Fee (PMPM) Growth	-	-2.64%	42.14%	26.82%
Other Revenue	5.41M	5.95M	8.5M	8.55M
Other Revenue Growth	-	9.84%	43.00%	0.52%

Frequently Asked Questions

Valuation & Price

Privia Health Group, Inc. (PRVA) has a price-to-earnings (P/E) ratio of 216.9x. This suggests investors expect higher future growth.

Growth & Financials

Privia Health Group, Inc. (PRVA) reported $2.04B in revenue for fiscal year 2024. This represents a 211% increase from $657.6M in 2018.

Privia Health Group, Inc. (PRVA) grew revenue by 4.7% over the past year. Growth has been modest.

Yes, Privia Health Group, Inc. (PRVA) is profitable, generating $18.2M in net income for fiscal year 2024 (0.8% net margin).

Dividend & Returns

Privia Health Group, Inc. (PRVA) has a return on equity (ROE) of 2.2%. This is below average, suggesting room for improvement.

Privia Health Group, Inc. (PRVA) generated $109.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.